|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02389 BJ HEALTH
Nominal 
0.085 +0.001 (+1.190%) | 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Turnover | 140,346 | -15.700% | 166,484 | 203,776 | 149,887 | 200,755 |
| Cost of Sales | (101,872) | -15.087% | (119,972) | (156,785) | (117,095) | (137,368) |
| Gross Profit | 38,474 | -17.282% | 46,512 | 46,991 | 32,792 | 63,387 |
| 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (15,163) | 49.995% | (10,109) | (7,030) | (33,960) | (63,284) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (23,020) | -47.078% | (43,498) | (17,885) | (43,280) | (17,916) | |
| Profit / (Loss) before Taxation | (68,778) | -33.028% | (102,696) | (46,619) | (200,710) | (480,118) | |
| Taxation | 7,057 | 81.367% | 3,891 | 6,385 | 721 | 4,036 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (161) | -- | 1,109 | 824 | 14,665 | 53,688 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (61,882) | -36.659% | (97,696) | (39,410) | (185,324) | (422,394) | |
| 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Net Finance Costs / (Income) | (15,231) | 17.252% | (12,990) | (18,412) | (29,444) | (20,975) |
| Depreciation & Amortisation | 24,211 | -6.906% | 26,007 | 34,181 | 31,924 | 33,420 |
| Directors' Emoluments | 6,491 | 13.738% | 5,707 | 6,820 | 6,541 | 8,623 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | -1.010 | -37.267% | -1.610 | -0.650 | -3.050 | -6.960 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | (0.007) | -- | (0.005) | (0.003) | 0.001 | (0.012) |
| NBV per share ($) | 0.311 | -- | 0.336 | 0.377 | 0.375 | 0.389 |
| Remarks: | Real time quote last updated: 06/11/2024 17:27 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -56,411,000 |
| %Change | 252.261% |
| EPS / (LPS) | HKD -0.009 |
| NBV Per Share ($) | HKD 0.298 |